Department of Chemical Engineering, Ben-Gurion University of the Negev, Beer Sheva, Israel.
Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel; Endocrinology, Soroka University Medical Center, Beer Sheva, Israel.
Acta Biomater. 2023 Apr 15;161:275-284. doi: 10.1016/j.actbio.2023.03.010. Epub 2023 Mar 16.
Thyroid nodules (TNs) are common neck ultrasonography (US) findings, yet only 5-10% of these nodules harbor thyroid cancer (TC). When US characteristics are consistent with an intermediate or high suspicion for TN malignancy, fine needle aspiration for cytology (FNAC) is indicated. The main limitation of FNAC is that cytological results can be indeterminate in up to 30% of cases, necessitating reevaluation through repeated FNAC, expensive molecular testing, or diagnostic thyroid lobe resection. As such, there is a need for further refinement of current diagnostic algorithms for TNs without subjecting patients to additional invasive procedures. As calcifications detected during thyroid US are considered a high-risk feature for malignancy, we used the material remaining following routine thyroid FNAC to isolate microscopic calcifications (MCs). We then characterized the elemental composition, morphology, and crystal phases of these MCs, ultimately revealing differences between the MCs from benign and malignant TNs. Specifically, thyroid MCs were identified as calcium phosphate crystals containing varying levels of magnesium, sodium, iron, and zinc. MCs obtained from malignant TNs, mainly papillary thyroid carcinoma, were composed of sub-micrometer spherical particles, whereas MCs from benign TNs consisted of faceted particles. While samples from most patients with a final diagnosis of malignant TNs (50% of them with indeterminate cytology) harbored zinc-containing MCs, zinc was largely absent in MCs from benign TNs (23% with indeterminate or non-diagnostic cytology). Together, these data suggest that the presence of zinc in MCs isolated from samples collected during routine FNAC may potentially offer value as a biomarker of TN malignancy. STATEMENT OF SIGNIFICANCE: As up to 40% of patients assessed for thyroid malignancy do not receive a definite diagnosis following thyroid nodule (TN) fine needle aspiration (FNA), there is a pressing need to improve the accuracy of current diagnostic algorithms. Chemical analyses of microscopic calcifications (MCs) may serve as a diagnostic target. We developed a straightforward protocol to chemically characterize MCs from excess material collected from TNs during routine FNA and found that these MCs differed between benign and malignant TNs. Specifically, zinc in TN-derived MCs may indicate a higher nodule malignancy risk, thus increasing the diagnostic accuracy of the FNA procedure, reducing the need for recurrent biopsies and diagnostic surgical procedures, and decreasing the costs, uncertainty, and stress faced by affected patients.
甲状腺结节(TNs)是颈部超声(US)常见的发现,但这些结节中只有 5-10% 存在甲状腺癌(TC)。当 US 特征与 TN 恶性的中度或高度可疑一致时,需要进行细针抽吸细胞学检查(FNAC)。FNAC 的主要限制在于细胞学结果在多达 30%的病例中可能不确定,需要通过重复 FNAC、昂贵的分子检测或诊断性甲状腺叶切除术进行重新评估。因此,需要进一步完善目前的 TN 诊断算法,而无需使患者接受额外的侵入性操作。由于甲状腺 US 检测到的钙化被认为是恶性的高危特征,我们使用常规甲状腺 FNAC 后剩余的材料来分离微观钙化(MCs)。然后,我们对这些 MCs 的元素组成、形态和晶体相进行了特征描述,最终揭示了良性和恶性 TNs 之间的 MCs 存在差异。具体来说,甲状腺 MCs 被鉴定为含有不同水平镁、钠、铁和锌的磷酸钙晶体。来自恶性 TNs(主要是甲状腺乳头状癌)的 MCs 由亚微米级球形颗粒组成,而来自良性 TNs 的 MCs 由多面体形颗粒组成。虽然大多数最终诊断为恶性 TNs 的患者(其中 50%的患者细胞学结果不确定)的样本中含有含锌的 MCs,但在良性 TNs 的 MCs 中锌则大量缺失(23%的患者细胞学结果不确定或无法诊断)。总之,这些数据表明,从常规 FNAC 采集的样本中分离出的 MCs 中锌的存在可能作为 TN 恶性的生物标志物具有潜在价值。
意义声明:由于多达 40%的甲状腺恶性评估患者在进行甲状腺结节(TN)细针抽吸(FNA)后未得到明确诊断,因此迫切需要改进当前诊断算法的准确性。微观钙化(MCs)的化学分析可以作为诊断目标。我们开发了一种简单的方案,用于对从常规 FNA 期间从 TN 收集的多余材料中分离出的 MCs 进行化学表征,发现这些 MCs 在良性和恶性 TNs 之间存在差异。具体来说,TN 来源的 MCs 中的锌可能表明结节恶性风险更高,从而提高 FNA 程序的诊断准确性,减少对反复活检和诊断性手术程序的需求,并降低受影响患者面临的成本、不确定性和压力。
J Clin Endocrinol Metab. 2024-10-3
Int J Mol Sci. 2023-10-13
Cochrane Database Syst Rev. 2016-3-1